cbdMD (YCBD) Total Current Liabilities (2016 - 2026)
cbdMD (YCBD) posted Total Current Liabilities of $2.8 million for Q4 2025, down 13.14% sequentially from $3.2 million in Q3 2025, and down 69.75% YoY from $9.2 million in Q4 2024.
cbdMD (YCBD) Total Current Liabilities (2016 - 2026) Analysis & Trends
cbdMD has reported Total Current Liabilities for 10 years, with the latest figure at $2.8 million in Q4 2025.
- Quarterly Total Current Liabilities fell 69.75% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.8 million (down 69.75% YoY) and the FY2025 annual result came in at $3.2 million, down 62.94% from the prior year.
- Total Current Liabilities retreated to $2.8 million in Q4 2025 per YCBD's latest filing, from $3.2 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $9.9 million in Q1 2025 and troughed at $2.8 million in Q4 2025.
- A 5-year average of $6.1 million and a median of $5.9 million in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities jumped 84.53% in 2024, then slumped 69.75% in 2025.
- Over 5 years, Total Current Liabilities stood at $6.8 million in 2021, then dropped by 17.87% to $5.6 million in 2022, then increased by 7.55% to $6.0 million in 2023, then soared by 53.55% to $9.2 million in 2024, then plunged by 69.75% to $2.8 million in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $2.8 million, $3.2 million, and $3.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 1.79 Bn |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 3.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.08 Mn |
| Dec 31, 2025 | 2.77 Mn |
| Sep 30, 2025 | 3.19 Mn |
| Jun 30, 2025 | 3.58 Mn |
| Mar 31, 2025 | 9.87 Mn |
| Dec 31, 2024 | 9.17 Mn |
| Sep 30, 2024 | 8.62 Mn |
| Jun 30, 2024 | 7.86 Mn |
| Mar 31, 2024 | 6.94 Mn |
| Dec 31, 2023 | 5.97 Mn |
| Sep 30, 2023 | 4.67 Mn |
| Jun 30, 2023 | 4.38 Mn |
| Mar 31, 2023 | 4.68 Mn |
| Dec 31, 2022 | 5.55 Mn |
| Sep 30, 2022 | 5.29 Mn |
| Jun 30, 2022 | 5.73 Mn |
| Mar 31, 2022 | 5.79 Mn |
| Dec 31, 2021 | 6.76 Mn |
| Sep 30, 2021 | 6.92 Mn |
| Jun 30, 2021 | 6.75 Mn |